NIH probes multidrug-resistant bacteria in community settings
By
Kristen Fischer
Sep 08, 2023
Researchers are seeing people in community health settings with extremely or unusually virulent strains of the bacteria Klebsiella pneumoniae. As a result, a National Institutes of Health research group...
Clinical briefs for Wednesday, April 17
By
Kristen Fischer
Apr 17, 2024
Leqembi slow to catch on, but spending may surge … Older adults in NYC missed out on COVID-19 vaccines early on due to misallocation of resources … Intergenerational program explores attitudes on...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
Clinical briefs for Thursday, March 23
By
Ron Rajecki
Mar 23, 2023
Rural nursing home residents reap benefits from mental healthcare through video … NIH: Prior COVID-19 infection dampens response to vaccination … Skirting cholesterol targets raises CV events by 44...
Clinical briefs for Wednesday, March 3
By
Alicia Lasek
Mar 03, 2021
Senior living chief medical officer reflects on COVID a year into pandemic, including vaccine acceptance … NIH halts convalescent plasma trial in ED patients with mild COVID symptoms … Stroke patients...
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...
Coronavirus vaccines must take elders’ weaker immune systems into account: report
By
Alicia Lasek
Jun 23, 2020
Residents’ weaker immune systems could dilute the effectiveness of future coronavirus vaccines. Solutions are in the works, finds a new report.